0001839882-23-004703.txt : 20230224 0001839882-23-004703.hdr.sgml : 20230224 20230224183739 ACCESSION NUMBER: 0001839882-23-004703 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAENGER BRADLEY CENTRAL INDEX KEY: 0001668150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 23669317 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 BUSINESS PHONE: 212-980-9155 MAIL ADDRESS: STREET 1: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 4 1 ownership.xml BENEFICIAL OWNERSHIP X0306 4 2023-02-23 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001668150 SAENGER BRADLEY C/O TONIX PHARMACEUTICALS HOLDING CORP 26 MAIN ST., SUITE 101 CHATHAM NJ 07928 0 1 0 0 Chief Financial Officer Stock Option 0.731 2023-02-23 4 A 0 200000 0.00 A 2024-02-23 2033-02-23 Common Stock 200000 200000 D Stock Option 0.914 2023-02-23 4 A 0 200000 0.00 A 2024-02-23 2033-02-23 Common Stock 200000 200000 D One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. /s/ Bradley Saenger 2023-02-24